Reverse transcriptase: Difference between revisions

Joel L. Sussman (talk | contribs)
No edit summary
Joel L. Sussman (talk | contribs)
No edit summary
Line 25: Line 25:
As a RNA-dependent DNA Polymerase, Reverse Transcriptase is able to recognize the initial RNA, transcribe it to ssDNA, cleave the remaining RNA and then build up the dsDNA. To do this the protein has two active catalytic zones. Chain A has the <scene name='Reverse_transcriptase/Fingers/4'>Polymerase active site</scene> that consist of two ''finger-like'' domains: one of them recognizes the initial nucleic acid by h-bond interactions with phosphate groups of the side chains, then both domains make a conformational change closing the recognition hole to allow the second domain with the support a  <scene name='Reverse_transcriptase/Magnesium/2'>Magnesium ion</scene> coordination system to begin the transcription process adding the specific DNA nucleotides. This change is allowed by a <scene name='Reverse_transcriptase/Flexible/2'>flexible zone</scene> between the two previous domains; it is used as a common pharmaceutical target site in order to prevent the change and therefore inhibit activity. This zone is the only zone of Chain A that has non-conserved aminoacids, giving the virus more drug resistance<ref>Consurf Data Base DOI: 10.1002/ijch.201200096</ref>
As a RNA-dependent DNA Polymerase, Reverse Transcriptase is able to recognize the initial RNA, transcribe it to ssDNA, cleave the remaining RNA and then build up the dsDNA. To do this the protein has two active catalytic zones. Chain A has the <scene name='Reverse_transcriptase/Fingers/4'>Polymerase active site</scene> that consist of two ''finger-like'' domains: one of them recognizes the initial nucleic acid by h-bond interactions with phosphate groups of the side chains, then both domains make a conformational change closing the recognition hole to allow the second domain with the support a  <scene name='Reverse_transcriptase/Magnesium/2'>Magnesium ion</scene> coordination system to begin the transcription process adding the specific DNA nucleotides. This change is allowed by a <scene name='Reverse_transcriptase/Flexible/2'>flexible zone</scene> between the two previous domains; it is used as a common pharmaceutical target site in order to prevent the change and therefore inhibit activity. This zone is the only zone of Chain A that has non-conserved aminoacids, giving the virus more drug resistance<ref>Consurf Data Base DOI: 10.1002/ijch.201200096</ref>


<ref>[http://dx.doi.org/10.1002/ijch.201200096 DOI: 10.1002/ijch.201200096]</ref
<ref>[http://dx.doi.org/10.1002/ijch.201200096 DOI: 10.1002/ijch.201200096]</ref>


  [http://consurfdb.tau.ac.il/chain_selection.php?pdb_ID=1JLB Link to Consurf Data Base for PDB Entry: 1JLB].
  [http://consurfdb.tau.ac.il/chain_selection.php?pdb_ID=1JLB Link to Consurf Data Base for PDB Entry: 1JLB].

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Eric Martz, Daniel Moyano-Marino, Lynmarie K Thompson, Alexander Berchansky, David Canner, Jaime Prilusky, Brian Foley, Michal Harel, Amol Kapoor, Joel L. Sussman